In this study, deletion of AMPKα1/α2 in donor T cells decreased allogeneic donor T cell numbers in a cell-intrinsic manner prior to day 3 posttransplant, in the process decreasing GVHD while simultaneously sparing lymphopenia-driven immune reconstitution and GVT effects. The gene discussed is PRKAA1; the disease is graft versus host disease.